HAVENWYCK HOSPITAL — History
CCN 234023 | 3-year financial timeline | COVID resilience: 62/100
🛡️ Public data only — no PHI permitted on this instance.
$74M
Latest Revenue (FY2022)
+8.6%
Revenue CAGR (3yr)
22.3%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $63M | $66M | $74M | +13.0% | +8.6% |
| Operating Expenses | $49M | $54M | $58M | +7.7% | +8.5% |
| Operating Margin | 22.2% | 18.5% | 22.3% | +20.9% | +0.3% |
| Net Income | $14M | $12M | $17M | +36.6% | +8.9% |
| Licensed Beds | 213 | 213 | 213 | +0.0% | +0.0% |
| Total Patient Days | 61,211 | 60,377 | 65,589 | +8.6% | +3.5% |
| Medicare Day % | 7% | 7% | 6% | -15.5% | -12.1% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 62/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +17.9% ($63M → $74M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▶ Stable
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+8.6%
This Hospital
+7.6%
State Avg
Latest Margin
22.3%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $80M | 22.4% |
| FY2024 (proj) | $85M | 22.4% |
| FY2025 (proj) | $91M | 22.5% |